• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Akt:细胞增殖和基因组稳定性的双刃剑。

Akt: a double-edged sword in cell proliferation and genome stability.

机构信息

Division of Life Science, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China.

出版信息

J Oncol. 2012;2012:951724. doi: 10.1155/2012/951724. Epub 2012 Mar 15.

DOI:10.1155/2012/951724
PMID:22481935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3317191/
Abstract

The Akt family of serine/threonine protein kinases are key regulators of multiple aspects of cell behaviour, including proliferation, survival, metabolism, and tumorigenesis. Growth-factor-activated Akt signalling promotes progression through normal, unperturbed cell cycles by acting on diverse downstream factors involved in controlling the G1/S and G2/M transitions. Remarkably, several recent studies have also implicated Akt in modulating DNA damage responses and genome stability. High Akt activity can suppress ATR/Chk1 signalling and homologous recombination repair (HRR) via direct phosphorylation of Chk1 or TopBP1 or, indirectly, by inhibiting recruitment of double-strand break (DSB) resection factors, such as RPA, Brca1, and Rad51, to sites of damage. Loss of checkpoint and/or HRR proficiency is therefore a potential cause of genomic instability in tumor cells with high Akt. Conversely, Akt is activated by DNA double-strand breaks (DSBs) in a DNA-PK- or ATM/ATR-dependent manner and in some circumstances can contribute to radioresistance by stimulating DNA repair by nonhomologous end joining (NHEJ). Akt therefore modifies both the response to and repair of genotoxic damage in complex ways that are likely to have important consequences for the therapy of tumors with deregulation of the PI3K-Akt-PTEN pathway.

摘要

丝氨酸/苏氨酸蛋白激酶 Akt 家族是细胞行为的多个方面的关键调节因子,包括增殖、存活、代谢和肿瘤发生。生长因子激活的 Akt 信号通过作用于参与控制 G1/S 和 G2/M 转变的各种下游因子,促进正常、未受干扰的细胞周期的进展。值得注意的是,最近的几项研究还表明 Akt 参与调节 DNA 损伤反应和基因组稳定性。高 Akt 活性可以通过直接磷酸化 Chk1 或 TopBP1 或间接抑制双链断裂 (DSB) 切除因子(如 RPA、Brca1 和 Rad51)向损伤部位募集来抑制 ATR/Chk1 信号和同源重组修复 (HRR)。因此,在 Akt 活性高的肿瘤细胞中,检查点和/或 HRR 功能丧失是基因组不稳定的潜在原因。相反,Akt 以依赖于 DNA-PK 或 ATM/ATR 的方式被 DNA 双链断裂 (DSBs) 激活,并且在某些情况下可以通过刺激非同源末端连接 (NHEJ) 来促进 DNA 修复,从而有助于放射抗性。因此,Akt 以复杂的方式修饰对遗传毒性损伤的反应和修复,这可能对 PI3K-Akt-PTEN 通路失调的肿瘤的治疗产生重要影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/42495a46cf36/JO2012-951724.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/4f2888c4d175/JO2012-951724.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/510bb18b9232/JO2012-951724.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/42495a46cf36/JO2012-951724.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/4f2888c4d175/JO2012-951724.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/510bb18b9232/JO2012-951724.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dcd/3317191/42495a46cf36/JO2012-951724.003.jpg

相似文献

1
Akt: a double-edged sword in cell proliferation and genome stability.Akt:细胞增殖和基因组稳定性的双刃剑。
J Oncol. 2012;2012:951724. doi: 10.1155/2012/951724. Epub 2012 Mar 15.
2
Proficiency in homologous recombination repair is prerequisite for activation of G-checkpoint at low radiation doses.同源重组修复能力是低剂量辐射激活 G 检验点的前提条件。
DNA Repair (Amst). 2021 May;101:103076. doi: 10.1016/j.dnarep.2021.103076. Epub 2021 Feb 20.
3
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.ATM-Chk2 和 ATR-Chk1 通路在 DNA 损伤信号转导和癌症中的作用。
Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0.
4
The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.异染色质对 DNA 双链断裂修复的影响:让沉默的强势者放松。
DNA Repair (Amst). 2010 Dec 10;9(12):1273-82. doi: 10.1016/j.dnarep.2010.09.013. Epub 2010 Oct 30.
5
Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase.辐射诱导的双链断裂需要 ATM,但在 S 期进行同源重组时不需要 Artemis。
Nucleic Acids Res. 2012 Sep 1;40(17):8336-47. doi: 10.1093/nar/gks604. Epub 2012 Jun 22.
6
Roles for the DNA-PK complex and 53BP1 in protecting ends from resection during DNA double-strand break repair.DNA-PK 复合物和 53BP1 在 DNA 双链断裂修复过程中保护末端免受切除的作用。
J Radiat Res. 2020 Sep 8;61(5):718-726. doi: 10.1093/jrr/rraa053.
7
DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair.DNA-PK、ATM 和 ATR 协同调节 p53-RPA 相互作用以促进同源重组 DNA 修复。
Oncogene. 2013 May 9;32(19):2452-62. doi: 10.1038/onc.2012.257. Epub 2012 Jul 16.
8
After double-strand break induction by UV-A, homologous recombination and nonhomologous end joining cooperate at the same DSB if both systems are available.在通过UV-A诱导双链断裂后,如果同源重组和非同源末端连接这两个系统都可用,它们会在同一个双链断裂处协同作用。
J Cell Sci. 2004 Oct 1;117(Pt 21):4935-45. doi: 10.1242/jcs.01355. Epub 2004 Sep 14.
9
The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function.DNA双链断裂的复杂性是激活ATR信号通路以进行G2/M期检查点调控的关键因素,而与ATM功能无关。
DNA Repair (Amst). 2015 Jan;25:72-83. doi: 10.1016/j.dnarep.2014.11.004. Epub 2014 Nov 24.
10
Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1.53BP1/RIF1介导的双链断裂(DSB)末端保护功能受损会刺激CtIP依赖的末端切除,并在G1期将修复转换为PARP1依赖的末端连接。
Oncotarget. 2016 Sep 6;7(36):57679-57693. doi: 10.18632/oncotarget.11023.

引用本文的文献

1
Phloridzin Mitigates Gorham-Stout Disease by Dual Inhibition of Osteoclastogenesis Related to the Ca Signaling Pathway and Vascular Proliferation.根皮苷通过双重抑制与钙信号通路和血管增殖相关的破骨细胞生成来减轻戈勒姆-斯托特病。
ACS Omega. 2025 Aug 18;10(33):37740-37760. doi: 10.1021/acsomega.5c04384. eCollection 2025 Aug 26.
2
An Update on Role of Ionizing Radiation to Enhance Proliferation and Differentiation of Normal Stem Cells via Activation of NRF2 Pathway: Review.电离辐射通过激活NRF2途径增强正常干细胞增殖和分化作用的最新进展:综述
Antioxidants (Basel). 2025 Aug 11;14(8):986. doi: 10.3390/antiox14080986.
3

本文引用的文献

1
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors.首个人体临床试验口服 pan-AKT 抑制剂 MK-2206 治疗晚期实体瘤。
J Clin Oncol. 2011 Dec 10;29(35):4688-95. doi: 10.1200/JCO.2011.35.5263. Epub 2011 Oct 24.
2
Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression.鉴定 PHLLP1 为肿瘤抑制因子揭示了反馈激活在 PTEN 突变型前列腺癌进展中的作用。
Cancer Cell. 2011 Aug 16;20(2):173-86. doi: 10.1016/j.ccr.2011.07.013.
3
Targeting the PI3K/Akt/mTOR pathway--beyond rapalogs.
Cell cycle regulation in cancer cells by O-GlcNAcylation.
O-连接的N-乙酰葡糖胺糖基化对癌细胞中细胞周期的调控
Glycoconj J. 2025 Aug 18. doi: 10.1007/s10719-025-10189-8.
4
Bisphenol A suppresses colon epithelial cell responses via G/G-phase arrest, MAPK and PI3K/AKT pathway modulation, and MMP-2/9 Inhibition by upregulating p21WAF1.双酚A通过G/G期阻滞、丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)信号通路调节以及上调p21WAF1抑制基质金属蛋白酶-2/9(MMP-2/9),从而抑制结肠上皮细胞反应。
Sci Rep. 2025 Jul 23;15(1):26698. doi: 10.1038/s41598-025-11700-9.
5
Enhanced inhibitory effects of mianserin in combination with sorafenib on liver cancer growth through targeting the CCR9-AKT pathway.米氮平与索拉非尼联合使用通过靶向CCR9-AKT途径增强对肝癌生长的抑制作用。
Am J Cancer Res. 2025 Jun 25;15(6):2890-2904. doi: 10.62347/CYDE4091. eCollection 2025.
6
Genome rearrangements induced by the stimulation of end-joining of DNA double strand breaks through multiple phosphorylation of MRE11 by the kinase PKB/AKT1.激酶PKB/AKT1通过对MRE11进行多次磷酸化作用来刺激DNA双链断裂的末端连接,从而诱导基因组重排。
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf468.
7
Anti-Inflammasome Effect of Impressic Acid on Diesel Exhaust Particulate Matter-Induced NLRP1 Inflammasome via the Keap1/p62/Nrf2-Signaling Pathway in Keratinocytes.印加酸通过角质形成细胞中的Keap1/p62/Nrf2信号通路对柴油废气颗粒物诱导的NLRP1炎性小体的抗炎作用
Antioxidants (Basel). 2025 May 19;14(5):610. doi: 10.3390/antiox14050610.
8
Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches.HIV相关淋巴瘤发生的病理机制:新型靶向治疗方法。
Cells. 2025 May 13;14(10):705. doi: 10.3390/cells14100705.
9
Atoh8 expression inhibition promoted osteogenic differentiation of ADSCs and inhibited cell proliferation in vitro and rat bone defect models.Atoh8表达抑制促进了脂肪来源干细胞的成骨分化,并在体外和大鼠骨缺损模型中抑制了细胞增殖。
Adipocyte. 2025 Dec;14(1):2494089. doi: 10.1080/21623945.2025.2494089. Epub 2025 May 12.
10
Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer.靶向脂筏中的hERG1/β1整合素复合物可增强他汀类药物在胰腺癌中的抗癌活性。
Cell Death Discov. 2025 Feb 3;11(1):39. doi: 10.1038/s41420-025-02321-2.
靶向PI3K/Akt/mTOR信号通路——超越雷帕霉素类似物
Oncotarget. 2010 Nov;1(7):530-543. doi: 10.18632/oncotarget.188.
4
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.ATM-Chk2 和 ATR-Chk1 通路在 DNA 损伤信号转导和癌症中的作用。
Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0.
5
PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation.PKB/Akt 通过电离辐射后上调 Mre11 的表达促进癌细胞中 DSB 的修复。
Oncogene. 2011 Feb 24;30(8):944-55. doi: 10.1038/onc.2010.467. Epub 2010 Oct 18.
6
PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.PI3K/Akt/mTOR 通路抑制剂在癌症中的应用:临床进展展望。
Curr Med Chem. 2010;17(35):4326-41. doi: 10.2174/092986710793361234.
7
Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells.下调 Rad51 表达可克服人非小细胞肺癌细胞对吉西他滨的耐药性。
J Pharmacol Exp Ther. 2010 Dec;335(3):830-40. doi: 10.1124/jpet.110.173146. Epub 2010 Sep 20.
8
Akt inhibitors in clinical development for the treatment of cancer.正在临床开发中用于癌症治疗的 Akt 抑制剂。
Expert Opin Investig Drugs. 2010 Nov;19(11):1355-66. doi: 10.1517/13543784.2010.520701. Epub 2010 Sep 16.
9
Nuclear phospho-Akt increase predicts synergy of PI3K inhibition and doxorubicin in breast and ovarian cancer.核磷酸化 Akt 的增加预示着 PI3K 抑制和阿霉素在乳腺癌和卵巢癌中的协同作用。
Sci Transl Med. 2010 Sep 8;2(48):48ra66. doi: 10.1126/scitranslmed.3000630.
10
Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2.在 G2 晚期,Akt/PKB 抑制 DNA 损伤处理和检验点激活。
J Cell Biol. 2010 Aug 9;190(3):297-305. doi: 10.1083/jcb.201003004. Epub 2010 Aug 2.